Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.
about
Coronary heart disease and hormone replacement therapy after the menopauseHormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy for preventing cardiovascular disease in post-menopausal womenEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Perimenopause and cognitionRole of estrogen in diastolic dysfunctionPostmenopausal hormones and coronary artery disease: potential benefits and risksNew evidence for cardiac benefit of postmenopausal hormone therapy.Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studiesConjugated estrogens for the treatment of menopausal symptoms: a review of safety data.Cardiovascular Disease in Women: Clinical Perspectives.Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesisNon-feminizing estrogens: a novel neuroprotective therapy.Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question.In Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal WomenTiming of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.Estrogen implants: embodiments of deeper problems in the marketing of drugs.The 2012 hormone therapy position statement of: The North American Menopause Society.Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study.A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.The assessment of non-feminizing estrogens for use in neuroprotection.IMS updated recommendations on postmenopausal hormone therapy.Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal womenNeuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.Post-genomic update on a classical candidate gene for coronary artery disease: ESR1Estradiol triggers sonic-hedgehog-induced angiogenesis during peripheral nerve regeneration by downregulating hedgehog-interacting proteinPregnancy followed by delivery may affect circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in women of reproductive age.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspectiveThe timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.Health related quality of life after combined hormone replacement therapy: randomised controlled trialThe timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.Vascular Effects of Early versus Late Postmenopausal Treatment with EstradiolNew evidence rekindles the hormone therapy debate.Vascular actions of estrogens: functional implications.Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.Postmenopausal hormone therapy and cardiovascular disease in perspective.Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
P2860
Q22248005-6CA19D5E-C894-4B72-AE61-E586C8453A8BQ24187326-08378D68-2C05-49FC-8D10-5B3C0F40168BQ24197712-CB6583E7-AA21-4AA9-9A9A-7EFB4C3F05DEQ24658109-E6F8D1C8-019B-4A64-97B9-7BC1D005911DQ27022259-7B3327DA-F2BF-4D62-BF17-9287894453EBQ27026798-739C94D9-07F6-4257-99D7-55A08761740BQ28221869-10053707-5FCD-49CA-8AE7-BD4F01B9DD5FQ30396979-D038B63B-F4FC-4EA5-A49E-34C0BB45BF56Q30634935-7F222343-DE66-46FE-A1F7-ED77026202C7Q30659580-3A3B1B32-F8C6-4DD8-A85E-AAD76C107FE0Q30743765-F29C2A7B-FC9D-40D8-BFC5-AA6F686B4658Q30868399-606D0C82-128B-490A-9DF7-82394FDB9651Q33693293-2E7DF429-A323-4EA4-BC63-EC98CE4E6D64Q33715371-9C69350F-306F-43C3-BA70-6B8D711364CAQ33796458-9950F465-9A67-44D8-BDEB-932B18F51637Q33862138-0603A871-B960-4B5E-9D72-63E70B4919B0Q33885656-AF86042F-EACF-4FF7-AF43-42507E90F497Q34050727-493A544E-392C-4712-9A21-7646F2BD381BQ34161400-491DD90D-4817-49F9-B9DF-15D7F38CD116Q34449454-5AD14D60-F00D-43E0-86EE-07A7CD8D5AD6Q34592585-BBDC6147-14DC-46EF-9BD0-CB1E17FBA508Q34612394-F06C8562-22B3-49CC-9349-A25673ABB162Q34624609-1474A667-DF07-4D07-ABB7-F7D06B4804E2Q34626471-8F86FEB6-AB80-4D7C-9661-D786210D1392Q34649417-F6C2D9E9-32A5-4DF4-A252-0126FF4E8B3CQ35657938-04A64144-5A53-4CEE-90D2-582AB85378BFQ35678406-75D46E85-9434-4DD1-8E07-06149F265D9EQ35870117-ED8B2E5B-0F59-41FD-828B-FECCD6D1A8BEQ35955255-A4472165-2C52-49D2-BB2C-14B6223485B2Q36781520-AB8984D3-5AD2-49DE-8985-C1D7D0127087Q36806086-2C0D8825-99EE-4868-BD96-3D31B750016EQ36836702-AC56DE86-64E8-487A-B705-2005C936523AQ36843105-E6EC89D1-6783-4181-8079-2F444A913C25Q36863876-BA92E2DE-5490-42B3-A699-29DD67D56620Q37038435-3153FEBE-BCC0-48D8-9DEA-FCF3EAFBDBCBQ37056135-BF8E423D-CA98-43DF-A3B7-EC6A4C7EDA1FQ37088243-E733BBEB-AAEB-4FEF-8EC3-0C33D6D6FD2CQ37174271-84C950B0-53AA-4144-91F0-CB9E3A52037CQ37234323-207F9788-2617-49DC-907C-A76984882048Q37416880-2ADF176C-F6F6-497E-93C4-4129578E4768
P2860
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Brief report: Coronary heart d ...... older women. A meta-analysis.
@ast
Brief report: Coronary heart d ...... older women. A meta-analysis.
@en
Brief report: Coronary heart d ...... older women. A meta-analysis.
@nl
type
label
Brief report: Coronary heart d ...... older women. A meta-analysis.
@ast
Brief report: Coronary heart d ...... older women. A meta-analysis.
@en
Brief report: Coronary heart d ...... older women. A meta-analysis.
@nl
prefLabel
Brief report: Coronary heart d ...... older women. A meta-analysis.
@ast
Brief report: Coronary heart d ...... older women. A meta-analysis.
@en
Brief report: Coronary heart d ...... older women. A meta-analysis.
@nl
P2093
P2860
P1476
Brief report: Coronary heart d ...... older women. A meta-analysis.
@en
P2093
Edwin E Salpeter
Elizabeth Greyber
Judith M E Walsh
Shelley R Salpeter
P2860
P304
P356
10.1111/J.1525-1497.2006.00389.X
P577
2006-04-01T00:00:00Z
P5875
P6179
1052685218